Related Experiment Video
Updated: Mar 21, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
18.9K
The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis
Yao-Jun Liao1, Jing-Ru Jiang2, San-Qing Jin1
11 Department of Anesthesiology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
Summary
This meta-analysis found no significant link between the COMT Val158Met polymorphism and migraine risk. Further research is needed to fully understand genetic factors contributing to migraine susceptibility.
Area of Science:
- Neuroscience
- Genetics
- Epidemiology
Background:
- The Catechol-O-methyltransferase (COMT) Val158Met polymorphism has been investigated as a potential risk factor for migraine.
- Previous studies on the association between COMT Val158Met polymorphism and migraine have yielded inconsistent results.
- A comprehensive meta-analysis is required to clarify this relationship.
Purpose of the Study:
- To systematically evaluate the association between the COMT Val158Met polymorphism and migraine risk.
- To synthesize evidence from existing studies using meta-analytic methods.
Main Methods:
- A meta-analysis was conducted using studies identified through searches of the WEB OF SCIENCE and EMBASE databases.
- The odds ratio (OR) with 95% confidence intervals (CI) were calculated to assess the strength of association.
- Five studies, comprising 979 cases and 1870 controls, were included.
Main Results:
- The overall meta-analysis did not reveal a significant association between COMT Val158Met polymorphism and migraine across various genetic models (multiplicative, dominant, additive, recessive).
- Subgroup analyses for Caucasian and Asian populations also showed no statistically significant associations.
- The calculated ORs and p-values indicated no evidence supporting COMT Val158Met as a migraine risk factor.
Conclusions:
- The COMT Val158Met polymorphism is not associated with an increased risk of migraine.
- This meta-analysis provides robust evidence against the role of this specific genetic variation in migraine susceptibility.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
106
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
106
01:29Pharmacogenomics: Identification of New Drug Targets
75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
01:28Human Genetics
1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
01:05Single Nucleotide Polymorphisms-SNPs
19.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.7K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
01:27Principles of Pharmacogenetics: Types of Genetic Variants
86
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
86